CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Balance Sheet
NYSEARCA:CANF - NYSE Arca - US13471N3008 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.83M | 4.28M | 2.98M | 4.39M | 8.27M | |||
| Marketable Securities | 5.00K | 19.00K | 8.00K | 237.00K | 75.00K | |||
| Receivables | 77.00K | 78.00K | 47.00K | 48.00K | 18.00K | |||
| Other Current Assets | 4.08M | 5.53M | 6.12M | 15.39M | 1.04M | |||
| Total Current Assets | 8.98M | 9.91M | 9.16M | 20.07M | 9.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 138.00K | 81.00K | 126.00K | 185.00K | 123.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 138.00K | 81.00K | 126.00K | 185.00K | 123.00K | |||
| TOTAL ASSETS | 9.12M | 9.99M | 9.28M | 20.25M | 9.52M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.03M | 971.00K | 823.00K | 958.00K | 374.00K | |||
| Accounts Payable | 618.00K | 427.00K | 896.00K | 954.00K | 561.00K | |||
| Other Current Liabilities | 405.00K | 622.00K | 783.00K | 818.00K | 334.00K | |||
| Total Current Liabilities | 2.05M | 2.02M | 2.50M | 2.73M | 1.27M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.63M | 1.73M | 2.31M | 3.14M | 2.18M | |||
| Total Non-Current Liabilities | 1.63M | 1.73M | 2.31M | 3.14M | 2.18M | |||
| TOTAL LIABILITIES | 3.68M | 3.75M | 4.81M | 5.87M | 3.45M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -166.36M | -158.48M | -150.85M | -140.67M | -125.47M | |||
| Additional Paid In Capital | 170.67M | 163.60M | 154.19M | 93.28M | 97.38M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 0.00 | 0.00 | N/A | 60.65M | 33.04M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | |||
| Shares Outstanding | 17.62M | 8.03M | 4.82M | 4.82M | 2.74M | |||
| Tangible Book Value per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | |||
| Total Shareholders' Equity | 5.44M | 6.24M | 4.47M | 14.38M | 6.07M | |||
| TOTAL LIABILITIES AND EQUITY | 9.12M | 9.99M | 9.28M | 20.25M | 9.52M | |||
| Statistics | ||||||||
| Current Ratio | 4.38 | 4.90 | 3.66 | 7.35 | 7.41 | |||
| Return On Assets (ROA) | -86.40% | -76.42% | -109.59% | -75.08% | -159.17% | |||
| Return On Equity (ROE) | -144.96% | -122.28% | -227.48% | -105.72% | -249.56% | |||
All data in USD , ROIC based on taxRate of 0.21